Brochure | May 13, 2020

Highly Potent Active Pharmaceutical Ingredients (HPAPIs)

Source: Lonza Pharma & Biotech

With the pharmaceutical industry’s focus on oncology and more targeted therapies, the number of highly potent active pharmaceutical ingredients (HPAPIs) in development continues to increase. as does the demand for HPAPI manufacturing capacity.  As described in this technical brief, Lonza has more than 20 years’ experience in the manufacture and handling of HPAPIs. Our expertise, capabilities, manufacturing innovation, and integrated service options are described. To learn more, please read our technical brief.

VIEW THE BROCHURE!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Drug Discovery Online? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
I'm interested in newsletter subscriptions.
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: